StockData
DarioHealth Corp. logo

DarioHealth Corp. (DRIO) stock

DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.15−0.11 (-8.73%)

Close on Nov 16, 2026Market cap $11.27MP/E 0.3Yield –

DarioHealth ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for DarioHealth

DarioHealth has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More DarioHealth figures

See a number that looks wrong?